Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Sklar Personal Care Inc.
WARNING LETTER
•Sklar Personal Care Inc.•June 9, 2025

Sklar Personal Care Inc. – FDA Warning Letter, Jun 9, 2025

Record Details

The FDA issued a Warning Letter to Sklar Personal Care Inc. following inspections of its Statesville, North Carolina drug manufacturing facility from May 19-23 and June 9, 2025. The letter identifies significant violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals (21 CFR parts 210 and 211), rendering their drug products adulterated under the Federal Food, Drug, and Cosmetic Act. Key violations include the firm"s failure to adequately test incoming raw materials for identity before use in OTC drug products, specifically neglecting to test certain materials for methanol contamination. This oversight means the firm lacks scientific evidence that its raw materials meet specifications. Additionally, Sklar Personal Care Inc. failed to establish and follow adequate written procedures for equipment cleaning and maintenance, lacking essential cleaning validation studies to prevent contamination. Lastly, the firm failed to establish adequate written procedures for production and process control, specifically neglecting to conduct process validations for its OTC drug products. The company"s responses to these observations were deemed inadequate, lacking comprehensive risk assessments and detailed corrective action plans. The FDA requires Sklar Personal Care Inc. to conduct a thorough review of its material system, implement robust testing for all components, establish detailed cleaning validation protocols, and develop comprehensive process validation for all drug products, including risk assessments for distributed products.

Company
Sklar Personal Care Inc.
Inspection date
June 9, 2025
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Francis Godwin (Director)
View Company Profile

ID · d7fd3bc9-5de5-4157-b9e2-c10356f1cf61

Violation Codes9
21 U.S.C. 351(a)(2)(B)21 CFR 211.100(a)FD&C Act 501(a)(2)(B)21 CFR 21121 CFR 21021 CFR 211.84(d)(1)21 CFR 211.67(b)21 CFR 211.3421 CFR 211.22(d)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Sklar Personal Care Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.